ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.sj-hospital.org
Clinical Trials
Related News

Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer

First Posted Date
2022-12-06
Last Posted Date
2023-03-20
Lead Sponsor
Shengjing Hospital
Target Recruit Count
236
Registration Number
NCT05638594
Locations
🇨🇳

Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

A Study of SHR-A1811 Monotherapy or Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients

Phase 2
Recruiting
Conditions
HER2-positive Breast Cancer
Interventions
Drug: SHR-A1811
Drug: Pyrotinib
First Posted Date
2022-12-02
Last Posted Date
2024-07-05
Lead Sponsor
Shengjing Hospital
Target Recruit Count
65
Registration Number
NCT05635487
Locations
🇨🇳

Shengjing Hospital affiliated to China Medical University, Shenyang, Liaoning, China

Management of FI After Surgery of ARM

First Posted Date
2022-11-18
Last Posted Date
2023-04-12
Lead Sponsor
Shengjing Hospital
Target Recruit Count
108
Registration Number
NCT05621629
Locations
🇨🇳

Shengjing Hospital, Shenyang, Liaoning, China

Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome and Transcriptome

Recruiting
Conditions
Microbiome
Infertility
Interventions
Other: no intervention
First Posted Date
2022-09-19
Last Posted Date
2022-09-19
Lead Sponsor
Shengjing Hospital
Target Recruit Count
300
Registration Number
NCT05545631
Locations
🇨🇳

Xiuxia Wang, Shenyang, Liaoning, China

A 14-item Questionnaire Regarding Career Preferences Among Chinese Medical Undergraduate Students.

Active, not recruiting
Conditions
Career Burnout
Student Burnout
Interventions
Other: Questionnaire Survey
First Posted Date
2022-09-08
Last Posted Date
2023-11-02
Lead Sponsor
Shengjing Hospital
Target Recruit Count
500
Registration Number
NCT05531487
Locations
🇨🇳

Shenjing Hospital of CHINA MEDICAL UNIVERSITY, Shenyang, Liaoning, China

A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis

Phase 2
Recruiting
Conditions
Plasma Cell Mastitis
Interventions
Drug: Traditional Chinese medicine
First Posted Date
2022-09-07
Last Posted Date
2022-09-07
Lead Sponsor
Shengjing Hospital
Target Recruit Count
50
Registration Number
NCT05530226
Locations
🇨🇳

Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome

Recruiting
Conditions
Infertility
Microbiome
Interventions
Other: no intervention
First Posted Date
2022-08-30
Last Posted Date
2022-09-19
Lead Sponsor
Shengjing Hospital
Target Recruit Count
3600
Registration Number
NCT05521295
Locations
🇨🇳

Xiuxia Wang, Shenyang, Liaoning, China

A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

First Posted Date
2022-08-02
Last Posted Date
2022-08-05
Lead Sponsor
Shengjing Hospital
Target Recruit Count
100
Registration Number
NCT05483439
Locations
🇨🇳

ShengJing ospital of China Medical University, Shenyang, Liaoning, China

🇨🇳

Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning, China

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

First Posted Date
2022-08-01
Last Posted Date
2023-11-03
Lead Sponsor
Shengjing Hospital
Target Recruit Count
2000
Registration Number
NCT05481242
Locations
🇨🇳

Shenjing Hospital of CHINA MEDICAL UNIVERSITY, Shenyang, Liaoning, China

Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

First Posted Date
2022-08-01
Last Posted Date
2023-11-02
Lead Sponsor
Shengjing Hospital
Target Recruit Count
2000
Registration Number
NCT05482269
Locations
🇨🇳

Shengjing Hospital, Shenyang, Liaoning, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy